PHLPP inhibition and Osteoarthritis-Associated Pain
PHLPP 抑制和骨关节炎相关疼痛
基本信息
- 批准号:10581073
- 负责人:
- 金额:$ 20.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:Afferent NeuronsAnimal ModelArthralgiaBehaviorBehavior TherapyBiological AssayBiological ModelsCartilageCellsChondrocytesChronicConfocal MicroscopyDataDegenerative polyarthritisDeteriorationDevelopmentDiseaseFibroblastsGoalsHumanHypersensitivityImmobilizationImmunohistochemistryIn VitroInduced pluripotent stem cell derived neuronsInjectionsInjuryIntra-Articular InjectionsJointsKnee InjuriesKnowledgeLaboratoriesMeasuresMedial meniscus structureMitochondriaMolecularMouse StrainsMusNatural regenerationNerve FibersNeuritesNeuronsNeurotransmittersNociceptionOperative Surgical ProceduresPainPain managementPathogenesisPathologicPathway interactionsPeriosteumPhenotypePhosphoric Monoester HydrolasesProtein phosphataseProteinsProteomicsPublishingRNARandomizedRattusReporterRoleSalineSensorySkinSpinal GangliaSubstance PTestingTimeTissuesTraumatic ArthropathyWorkafferent nerveaggrecanallodyniaarticular cartilagecartilage degradationcartilage regenerationexperimental studyhealthy volunteerin vivoinduced pluripotent stem cellinhibitorinnovationjoint stiffnessmultidisciplinarynerve supplyneurofilamentosteoarthritis painpain behaviorpain reductionpain reliefpalliativepreventregenerativesham surgerysmall molecule inhibitorsubchondral bonetranscriptometranscriptomics
项目摘要
ABSTRACT
Osteoarthritis (OA) is a progressive and debilitating disease characterized by deterioration of articular cartilage
and pathologic changes to other tissues leading to joint stiffness and pain. Non-surgical treatments focus on
behavior modifications and pain relief, but little is known about the molecular pathways controlling nociception
during OA pathogenesis. In this project, we will examine how controlling the activity of PHLPP phosphatases
contributes to joint innervation in vivo and neurite extension in vitro.
We identified PHLPPs as suppressors of chondrocyte regeneration and pain-related behaviors. PHLPP1 and
PHLPP2 are present in human and mouse sensory neurons and abnormally expressed in human OA cartilage.
In an animal model of OA, intra-articular injection of PHLPP inhibitors prevented joint hypersensitivity and
cartilage degradation and reduced sensory neuron innervation of joint tissues (e.g., subchondral bone,
periosteum). PHLPP inhibitors suppressed outgrowth of small/medium sensory neurons and expression of
neurotransmitters and neurofilaments in vitro. The goal of this project is to determine the mechanisms by
which small molecule inhibitors of PHLPP phosphatases suppress OA-associated pain. The central
hypothesis is that PHLPP inhibitors prevent innervation of osteoarthritic joints and alter molecular pathways
controlling sensory neurite extension. We will study mechanisms by which PHLPP inhibitors prevent neurite
extension and joint pain after knee injury with sensitive murine reporters of innervation and with human iPSC-
derived sensory neuron model systems.
抽象的
骨关节炎 (OA) 是一种进行性、使人衰弱的疾病,其特征是关节软骨退化
其他组织的病理变化导致关节僵硬和疼痛。非手术治疗的重点是
行为改变和疼痛缓解,但人们对控制伤害感受的分子途径知之甚少
在 OA 发病过程中。在这个项目中,我们将研究如何控制 PHLPP 磷酸酶的活性
有助于体内的关节神经支配和体外的神经突延伸。
我们确定 PHLPP 是软骨细胞再生和疼痛相关行为的抑制剂。 PHLPP1 和
PHLPP2 存在于人和小鼠感觉神经元中,并在人 OA 软骨中异常表达。
在 OA 动物模型中,关节内注射 PHLPP 抑制剂可预防关节过敏和
软骨退化和关节组织(例如软骨下骨、
骨膜)。 PHLPP 抑制剂抑制小/中感觉神经元的生长和
体外神经递质和神经丝。该项目的目标是通过以下方式确定机制:
PHLPP 磷酸酶的小分子抑制剂可抑制 OA 相关疼痛。中央
假设 PHLPP 抑制剂可防止骨关节炎关节的神经支配并改变分子途径
控制感觉神经突的延伸。我们将研究 PHLPP 抑制剂预防神经突的机制
使用敏感的神经支配小鼠报告基因和人类 iPSC- 来评估膝关节损伤后的伸展和关节疼痛
衍生的感觉神经元模型系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nathan P Staff其他文献
Nathan P Staff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nathan P Staff', 18)}}的其他基金
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity
研究 MAP2 在化疗引起的周围神经毒性中的作用
- 批准号:
10559108 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology
使用患者来源的 iPSC 技术评估化疗引起的周围神经病变的易感性
- 批准号:
9763518 - 财政年份:2017
- 资助金额:
$ 20.99万 - 项目类别:
Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology
使用患者来源的 iPSC 技术评估化疗引起的周围神经病变的易感性
- 批准号:
9450944 - 财政年份:2017
- 资助金额:
$ 20.99万 - 项目类别:
Mechanisms of Bortezomib-induced Peripheral Neuropathy
硼替佐米诱发周围神经病变的机制
- 批准号:
9093719 - 财政年份:2012
- 资助金额:
$ 20.99万 - 项目类别:
Mechanisms of Bortezomib-induced Peripheral Neuropathy
硼替佐米诱发周围神经病变的机制
- 批准号:
8505004 - 财政年份:2012
- 资助金额:
$ 20.99万 - 项目类别:
Mechanisms of Bortezomib-induced Peripheral Neuropathy
硼替佐米诱发周围神经病变的机制
- 批准号:
8677584 - 财政年份:2012
- 资助金额:
$ 20.99万 - 项目类别:
Mechanisms of Bortezomib-induced Peripheral Neuropathy
硼替佐米诱发周围神经病变的机制
- 批准号:
8350911 - 财政年份:2012
- 资助金额:
$ 20.99万 - 项目类别:
Dopaminergic modulation of CA1 intrinsic excitability
CA1 内在兴奋性的多巴胺能调节
- 批准号:
6719028 - 财政年份:2002
- 资助金额:
$ 20.99万 - 项目类别:
Dopaminergic modulation of CA1 intrinsic excitability
CA1 内在兴奋性的多巴胺能调节
- 批准号:
6634372 - 财政年份:2002
- 资助金额:
$ 20.99万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




